Skip to content

IN8BIO, INC.

INAB

CIK 0001740279

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$19.59M
+36.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$4.51
+74.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$23.86M
Q1 May 2026
Cash
$22.16M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
9.85M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings